TY - JOUR
T1 - Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers
AU - Zeliadt, Steven B.
AU - Hoffman, Richard M.
AU - Birkby, Genevieve
AU - Eberth, Jan M.
AU - Brenner, Alison T.
AU - Reuland, Daniel S.
AU - Flocke, Susan A.
N1 - Funding Information:
This research is the result of work conducted by six of the Cancer Prevention and Control Research Network sites funded by the Centers for Disease Control and Prevention and the National Cancer Institute. We wish to thank other members of the Tobacco and Lung Cancer Screening Workgroup and staff that supported the conduct of this research. We particularly thank Brittany Lavanty, MS and Rebecca Williams, PhD for assisting with programming the web-based survey. The research was supported by the following cooperative agreements from the Centers for Disease Control and Prevention, Prevention Research Program and the National Cancer Institute: U48DP005030, U48DP005013, U48DP005014, U48DP005017, U48DP005021, and U48DP005000. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention and National Cancer Institute.
Publisher Copyright:
© 2018
PY - 2018/4
Y1 - 2018/4
N2 - Introduction: The purpose of this study is to identify issues faced by Federally Qualified Health Centers (FQHCs) in implementing lung cancer screening in low-resource settings. Methods: Medical directors of 258 FQHCs serving communities with tobacco use prevalence above the median of all 1,202 FQHCs nationally were sampled to participate in a web-based survey. Data were collected between August and October 2016. Data analysis was completed in June 2017. Results: There were 112 (43%) FQHC medical directors or surrogates who responded to the 2016 survey. Overall, 41% of respondents were aware of a lung cancer screening program within 30 miles of their system's largest clinic. Although 43% reported that some providers in their system offer screening, it was typically at a very low volume (less than ten/month). Although FQHCs are required to collect tobacco use data, only 13% indicated that these data can identify patients eligible for screening. Many FQHCs reported important patient financial barriers for screening, including lack of insurance (72%), preauthorization requirements (58%), and out-of-pocket cost burdens for follow-up procedures (73%). Only 51% indicated having adequate access to specialty providers to manage abnormal findings, and few reported that leadership had either committed resources to lung cancer screening (12%) or prioritized lung cancer screening (12%). Conclusions: FQHCs and other safety-net clinics, which predominantly serve low-socioeconomic populations with high proportions of smokers eligible for lung cancer screening, face significant economic and resource challenges to implementing lung cancer screening. Although these vulnerable patients are at increased risk for lung cancer, reducing patient financial burdens and appropriately managing abnormal findings are critical to ensure that offering screening does not inadvertently lead to harm and increase disparities.
AB - Introduction: The purpose of this study is to identify issues faced by Federally Qualified Health Centers (FQHCs) in implementing lung cancer screening in low-resource settings. Methods: Medical directors of 258 FQHCs serving communities with tobacco use prevalence above the median of all 1,202 FQHCs nationally were sampled to participate in a web-based survey. Data were collected between August and October 2016. Data analysis was completed in June 2017. Results: There were 112 (43%) FQHC medical directors or surrogates who responded to the 2016 survey. Overall, 41% of respondents were aware of a lung cancer screening program within 30 miles of their system's largest clinic. Although 43% reported that some providers in their system offer screening, it was typically at a very low volume (less than ten/month). Although FQHCs are required to collect tobacco use data, only 13% indicated that these data can identify patients eligible for screening. Many FQHCs reported important patient financial barriers for screening, including lack of insurance (72%), preauthorization requirements (58%), and out-of-pocket cost burdens for follow-up procedures (73%). Only 51% indicated having adequate access to specialty providers to manage abnormal findings, and few reported that leadership had either committed resources to lung cancer screening (12%) or prioritized lung cancer screening (12%). Conclusions: FQHCs and other safety-net clinics, which predominantly serve low-socioeconomic populations with high proportions of smokers eligible for lung cancer screening, face significant economic and resource challenges to implementing lung cancer screening. Although these vulnerable patients are at increased risk for lung cancer, reducing patient financial burdens and appropriately managing abnormal findings are critical to ensure that offering screening does not inadvertently lead to harm and increase disparities.
UR - http://www.scopus.com/inward/record.url?scp=85041678779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041678779&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2018.01.001
DO - 10.1016/j.amepre.2018.01.001
M3 - Article
C2 - 29429606
AN - SCOPUS:85041678779
SN - 0749-3797
VL - 54
SP - 568
EP - 575
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 4
ER -